Cargando…
Tenfibgen Ligand Nanoencapsulation Delivers Bi-Functional Anti-CK2 RNAi Oligomer to Key Sites for Prostate Cancer Targeting Using Human Xenograft Tumors in Mice
Protected and specific delivery of nucleic acids to malignant cells remains a highly desirable approach for cancer therapy. Here we present data on the physical and chemical characteristics, mechanism of action, and pilot therapeutic efficacy of a tenfibgen (TBG)-shell nanocapsule technology for tum...
Autores principales: | Trembley, Janeen H., Unger, Gretchen M., Korman, Vicci L., Abedin, Md. Joynal, Nacusi, Lucas P., Vogel, Rachel I., Slaton, Joel W., Kren, Betsy T., Ahmed, Khalil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198192/ https://www.ncbi.nlm.nih.gov/pubmed/25333839 http://dx.doi.org/10.1371/journal.pone.0109970 |
Ejemplares similares
-
CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors
por: Ahmed, Khalil, et al.
Publicado: (2016) -
CK2 Molecular Targeting—Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer
por: Trembley, Janeen H., et al.
Publicado: (2017) -
CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression
por: Trembley, Janeen H., et al.
Publicado: (2019) -
Protein kinase CK2 – diverse roles in cancer cell biology and therapeutic promise
por: Trembley, Janeen H., et al.
Publicado: (2022) -
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy
por: Kren, Betsy T, et al.
Publicado: (2015)